Serdar Can Güven

533 total citations
67 papers, 330 citations indexed

About

Serdar Can Güven is a scholar working on Infectious Diseases, Rheumatology and Surgery. According to data from OpenAlex, Serdar Can Güven has authored 67 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 20 papers in Rheumatology and 16 papers in Surgery. Recurrent topics in Serdar Can Güven's work include COVID-19 Clinical Research Studies (17 papers), Inflammasome and immune disorders (9 papers) and Spondyloarthritis Studies and Treatments (7 papers). Serdar Can Güven is often cited by papers focused on COVID-19 Clinical Research Studies (17 papers), Inflammasome and immune disorders (9 papers) and Spondyloarthritis Studies and Treatments (7 papers). Serdar Can Güven collaborates with scholars based in Türkiye, United Kingdom and United States. Serdar Can Güven's co-authors include Berkan Armağan, Levent Özçakar, Abdülsamet Erden, Orhan Küçükşahin, Ahmet Omma, Hakan Babaoğlu, Berna Göker, Özkan Varan, Hamit Küçük and Abdurrahman Tufan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Serdar Can Güven

53 papers receiving 324 citations

Peers

Countries citing papers authored by Serdar Can Güven

Since Specialization

Citations

This map shows the geographic impact of Serdar Can Güven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdar Can Güven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdar Can Güven more than expected).

Fields of papers citing papers by Serdar Can Güven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdar Can Güven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdar Can Güven. The network helps show where Serdar Can Güven may publish in the future.

Co-authorship network of co-authors of Serdar Can Güven

This figure shows the co-authorship network connecting the top 25 collaborators of Serdar Can Güven. A scholar is included among the top collaborators of Serdar Can Güven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdar Can Güven. Serdar Can Güven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments 2025 ·AYBU AVESIS ·(unknown), Hakan Babaoğlu, (unknown), (unknown), (unknown), Serdar Can Güven, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), İsmail Doğan, (unknown), Ahmet Omma, Orhan Küçükşahin, Şükran Erten, Berkan Armağan	0
2	The role of high large unstained cell percentages in ongoing inflammation in the intercritical gout 2025 ·Joint Diseases and Related Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hakan Babaoğlu, Berkan Armağan, İsmail Doğan, Serdar Can Güven	0
3	Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients 2024 ·Wiener klinische Wochenschrift ·(unknown), Berkan Armağan, (unknown), (unknown), Serdar Can Güven, (unknown), (unknown), (unknown), (unknown), (unknown), İsmail Doğan, (unknown), Ahmet Omma, (unknown), Şükran Erten, Hakan Babaoğlu	1
4	Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis 2023 ·Archives of Rheumatology ·(unknown), Serdar Can Güven, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hüseyin Tutkak, Şebnem Ataman	2
5	Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis 2023 ·Laboratory Medicine ·(unknown), Abdülsamet Erden, (unknown), Serdar Can Güven, Berkan Armağan, (unknown), (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin	2
6	COVID‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab 2023 ·International Journal of Rheumatic Diseases ·Berkan Armağan, (unknown), (unknown), (unknown), (unknown), (unknown), Serdar Can Güven, Abdülsamet Erden, Orhan Küçükşahin, Ahmet Omma, Şükran Erten	1
7	Ustekinumab in Enteropathic Arthritis 2023 ·Immunotherapy ·(unknown), Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, (unknown), Yasemin Özın, Ahmet Omma, Orhan Küçükşahin	4
8	Tofacitinib experience in patients with enteropathic arthritis 2023 ·Immunotherapy ·(unknown), Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, (unknown), Yasemin Özın, Ahmet Omma, Orhan Küçükşahin	2
9	A single‐center COVID‐19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients 2022 ·International Journal of Rheumatic Diseases ·Serdar Can Güven, (unknown), (unknown), (unknown), (unknown), (unknown), Berkan Armağan, Kevser Gök, İsmail Doğan, (unknown), Abdülsamet Erden, Şükran Erten, Orhan Küçükşahin, Ahmet Omma	4
10	Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review 2022 ·Immunotherapy ·(unknown), Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin	4
11	Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center 2022 ·Immunopharmacology and Immunotoxicology ·Berkan Armağan, (unknown), Serdar Can Güven, (unknown), (unknown), (unknown), Abdülsamet Erden, Kevser Gök, (unknown), İsmail Doğan, Orhan Küçükşahin, Şükran Erten, Ahmet Omma	2
12	Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease 2022 ·Lara D. Veeken ·Abdülsamet Erden, (unknown), Antonis Fanouriakis, Serdar Can Güven, Berkan Armağan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin, George Βertsias, Dimitrios T. Boumpas	8
13	Eosinophilic granulomatosis with polyangiitis as a rare cause of the syndrome of inappropriate antidiuretic hormone secretion 2022 ·Irish Journal of Medical Science (1971 -) ·(unknown), (unknown), Serdar Can Güven, Cevdet Aydın, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakır	1
14	Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study 2022 ·International Journal of Rheumatic Diseases ·(unknown), Abdülsamet Erden, Berkan Armağan, Serdar Can Güven, (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin	6
15	Restless leg syndrome and sleep quality in granulomatosis with polyangiitis 2022 ·Serdar Can Güven, (unknown), (unknown), Berkan Armağan, Abdülsamet Erden, Orhan Küçükşahin, Ahmet Omma	1
16	Clinical Course of Idiopathic Inflammatory Myopathies in the COVID-19 Pandemic: A single-center Experience 2022 ·Future Virology ·(unknown), Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, (unknown), (unknown), (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin	2
17	Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients 2022 ·The Journal of Infection in Developing Countries ·Ahmet Omma, Abdülsamet Erden, (unknown), (unknown), (unknown), (unknown), Serdar Can Güven, Berkan Armağan, Selma Karaahmetoğlu, İhsan Ateş, Orhan Küçükşahin	1
18	Effects of anti‐SARS‐CoV‐2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort 2022 ·International Journal of Rheumatic Diseases ·(unknown), Abdülsamet Erden, Serdar Can Güven, Berkan Armağan, (unknown), (unknown), (unknown), (unknown), Ahmet Omma, Orhan Küçükşahin	7
19	Effects of COVID-19 on axial spondyloarthritis disease flare 2022 ·SHILAP Revista de lepidopterología ·Berkan Armağan, (unknown), (unknown), (unknown), (unknown), Serdar Can Güven, İsmail Doğan, Orhan Küçükşahin, Abdülsamet Erden	0
20	Effect of supervision on ultrasonographic measurements. A blinded randomized cross-over study. 2013 ·PubMed ·Levent Özçakar, Murat Kara, Levent Tekin, (unknown), (unknown), (unknown), Serdar Can Güven, (unknown), (unknown), (unknown), (unknown), Cengizhan Açıkel	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact